Latest News


Musculoskeletal

Philanthropy supporting our emerging leaders .

Funding from the Skipper Jacobs Charitable Trust has helped a group of our young research leaders broaden their experience and establish new collaborations. Close to $40,000 was shared amongst five early-to-mid career researchers, allowing them to travel nationally and internationally to progress their research and develop new skills. One of those to receive funding is Dr Kenji Fujita, an early-car.....
Read more

Category: Awards, Funding support, Research Excellence

Significant investment in our research announced.

A large collection of research projects will get off the ground following generous funding through the Ramsay Research and Teaching Fund Scheme. The scheme has directed more than $10 million to research on the Royal North Shore Hospital campus over the last 20 years, and this year a further $850,000 will be shared across 17 projects. A diverse range of studies will be supported, strengthening inves.....
Read more

Category: Awards, Funding support, Research Excellence

Crucial funds strengthening our research expertise.

A group of young researchers will have the chance to broaden their skills and establish new collaborations following a funding boost from the Royal North Shore Hospital Scientific Staff Council. The council has awarded 12 travel grants to scientists working within the district and the Kolling Institute. The diverse group of young leaders is driving research progress into heart and kidney disease, c.....
Read more

Category: Funding support, Research Excellence

Researchers offer the latest evidence around supplements for osteoarthritis.

With a large number of people relying on supplements to reduce their osteoarthritis pain, our researchers at the Kolling Institute have conducted a much-needed review of the most popular ones. The condition is impacting an increasing number of people, with many experiencing joint pain and functional impairment due to the disabling disease. Sadly, there is a lack of effective drugs to treat the cond.....
Read more

Category: Musculoskeletal Research, Research Excellence

New research to determine best practice for knee osteoarthritis.

Our researchers at the Kolling Institute are set to influence the delivery of osteoarthritis care across Australia following a significant funding announcement. More than $1.4 million has been awarded to internationally recognised rheumatologist and researcher Professor David Hunter as part of the NHMRC Partnership Project Grants Scheme. The scheme is designed to help researchers work directly with.....
Read more

Category: Musculoskeletal Research, Research Excellence

Technology delivering support to those with back pain anywhere, any time.

With the number of people living with low back pain escalating sharply, researchers are turning to widely-accessible technology to reduce the impact of the disabling condition. The team from the University of Sydney and the Kolling Institute has launched a study measuring the effectiveness of a mobile health program which offers self-management strategies via text messages. Study lead Professor Man.....
Read more

Category: Musculoskeletal Research, New Treatment, Research Excellence

Australian researchers uniquely positioned to support upcoming space missions.

The expertise across Australia’s space medicine community was showcased during a special event co-ordinated by the Kolling Institute and the Australasian Society of Aerospace Medicine. Staged over two days, the colloquium involved national and international experts including representatives from the Australian Space Agency, the CSIRO, Boeing and the Australian Antarctic Program. Presenters discusse.....
Read more

Category: New Treatment, Research Excellence

Kolling Institute Year in Review 2022 .

Check out our Kolling Institute Year in Review 2022 celebrating our research success. It highlights our world-leading translational research and our impact across our priority research areas. Click on the link here.
Read more

Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research

Research questions the value of injectable medications for osteoarthritis.

Our researchers at the Kolling Institute are encouraging those with osteoarthritis to rely on treatments with a proven track record and avoid quick fixes without the data to show they work. The comments follow a steady rise in osteoarthritis cases nationally, with around three million Australians now living with the condition, and many forced to retire early. The rise in cases has coincided with st.....
Read more

Category: Musculoskeletal Research, Research Excellence

Back pain cases to rise sharply.

A new study by researchers at the Kolling Institute estimates more than 800 million people will be living with low back pain by 2050, a 36 percent increase from 2020. The prediction follows an analysis of 30 years of global health data from over 200 countries. Modelling shows the number of back pain cases globally will rise to 843 million people by 2050, while in Australia, it’s expected there will.....
Read more

Category: Musculoskeletal Research